Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Vomiting 31Nausea 27Neoplasms 14Lymphoma, Non-Hodgkin 8Leukemia, Myeloid, Acute 7Multiple Myeloma 6Breast Neoplasms 6Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Burkitt Lymphoma 5Sezary Syndrome 4Primary Myelofibrosis 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myeloproliferative Disorders 4Mycosis Fungoides 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia, Hairy Cell 4Hodgkin Disease 4Uterine Cervical Neoplasms 3Pdgfra-Associated Chronic Eosinophilic Leukemia 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Myelodysplastic Syndromes 3Lymphoma, Large-Cell, Anaplastic 3

Interventions

Etoposide 156Carboplatin 146Cisplatin 106Topotecan 76durvalumab 52atezolizumab 51Irinotecan 45pembrolizumab 39Paclitaxel 34Nivolumab 33Radiotherapy 31PM 01183 25Drug Therapy 24anlotinib 23Gemcitabine 21apatinib 19Ipilimumab 18Docetaxel 17Temozolomide 16Platinum 16Radiosurgery 15Pemetrexed 14toripalimab 13tislelizumab 13olaparib 13Magnetic Resonance Spectroscopy 13Bevacizumab 13rovalpituzumab tesirine 11amrubicin 11Specimen Handling 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Ondansetron × Clear all
NCT04209595 2025-03-17

PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
10 enrolled 13 charts
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡